| Display title | Chemistry:Lubazodone |
| Default sort key | Lubazodone |
| Page length (in bytes) | 4,544 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 518905 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>HamTop |
| Date of page creation | 03:11, 9 March 2024 |
| Latest editor | imported>HamTop |
| Date of latest edit | 03:11, 9 March 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Lubazodone (developmental code names YM-992, YM-35995) is an experimental antidepressant which was under development by Yamanouchi for the treatment for major depressive disorder in the late 1990s and early 2000s but was never marketed. It acts as a serotonin reuptake inhibitor (Ki for SERT = 21 ... |
